These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8914859)

  • 1. Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats.
    Kolta MG; Ngong JM; Rutledge LP; Pierzchala K; Van Loon GR
    Neuropeptides; 1996 Aug; 30(4):335-44. PubMed ID: 8914859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic system modulation of nociceptive response in long-term diabetic rats.
    Rutledge LP; Ngong JM; Kuperberg JM; Samaan SS; Soliman KF; Kolta MG
    Pharmacol Biochem Behav; 2002 Dec; 74(1):1-9. PubMed ID: 12376147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a rat model of type II diabetic neuropathic pain.
    Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
    Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.
    Sugimoto K; Rashid IB; Shoji M; Suda T; Yasujima M
    J Pain; 2008 Mar; 9(3):237-45. PubMed ID: 18331706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats.
    Otto KJ; Wyse BD; Cabot PJ; Smith MT
    Pain Med; 2011 May; 12(5):782-93. PubMed ID: 21481170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-dependent attenuation in alpha 2-adrenoreceptor-mediated nociception in experimental diabetes.
    Bitar MS; Pilcher CW
    Pharmacol Biochem Behav; 1997 Jan; 56(1):15-20. PubMed ID: 8981604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
    Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
    Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
    Kiguchi S; Imamura T; Ichikawa K; Kojima M
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.
    Qinna NA; Badwan AA
    Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the gene expression of specific G-protein subunits correlate with morphine insensitivity in streptozotocin-induced diabetic rats.
    Hajializadeh Z; Esmaeili-Mahani S; Sheibani V; Kaeidi A; Atapour M; Abbasnejad M
    Neuropeptides; 2010 Aug; 44(4):299-304. PubMed ID: 20334911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
    Wright BE; Vasselli JR; Katovich MJ
    Physiol Behav; 1998 Mar; 63(5):867-74. PubMed ID: 9618010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma leptin in diabetic and insulin-treated diabetic and normal rats.
    Sivitz WI; Walsh S; Morgan D; Donohoue P; Haynes W; Leibel RL
    Metabolism; 1998 May; 47(5):584-91. PubMed ID: 9591751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum glucose level-dependent and independent modulation of mu-opioid agonist-mediated analgesia in diabetic mice.
    Kamei J; Kawashima N; Kasuya Y
    Life Sci; 1993; 52(1):53-60. PubMed ID: 8380216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats.
    Cheng JT; Liu IM; Chi TC; Tzeng TF; Lu FH; Chang CJ
    Diabetes; 2001 Dec; 50(12):2815-21. PubMed ID: 11723065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of nociceptive responses to mu and kappa opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats.
    Tandon M; Srivastava RK; Nagpal RK; Khosla P; Singh J
    Indian J Exp Biol; 2000 Mar; 38(3):242-8. PubMed ID: 10927866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
    Chen SR; Pan HL
    Anesthesiology; 2003 Jan; 98(1):217-22. PubMed ID: 12503000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain threshold in diabetic rats: effects of good versus poor diabetic control.
    Lee JH; McCarty R
    Pain; 1992 Aug; 50(2):231-236. PubMed ID: 1408322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.